Becton, Dickinson and Company (BDX) Q2 2024 Earnings
Becton, Dickinson and Company reported Q2 2024 revenue of $5.0B, beat analyst consensus of $5.0B by $7.4M. Diluted EPS came in at $3.17, beat the $2.97 consensus by $0.20. Becton, Dickinson and Company reports across 3 business segments, led by Medical, Life Sciences, and Interventional.
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Becton, Dickinson and Company's Q2 2024 earnings report.
Becton, Dickinson and Company (BDX) reported Q2 2024 earnings on May 2, 2024 before market open.
Becton, Dickinson and Company reported revenue of $5.0B and diluted EPS of $3.17 for Q2 2024.
Revenue beat the consensus estimate of $5.0B by $7.4M. EPS beat the consensus estimate of $2.97 by $0.20.
You can read the 10-Q periodic report (0000010795-24-000039) directly on SEC EDGAR. The filing index links above go to sec.gov.